These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. beta-Keto sulfones as inhibitors of 11beta-hydroxysteroid dehydrogenase type I and the mechanism of action. Xiang J; Ipek M; Suri V; Tam M; Xing Y; Huang N; Zhang Y; Tobin J; Mansour TS; McKew J Bioorg Med Chem; 2007 Jul; 15(13):4396-405. PubMed ID: 17490884 [TBL] [Abstract][Full Text] [Related]
9. Targeting JAK3 and BTK tyrosine kinases with rationally-designed inhibitors. Vassilev AO; Tibbles HE; DuMez D; Venkatachalam TK; Uckun FM Curr Drug Targets; 2006 Mar; 7(3):327-43. PubMed ID: 16515530 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of Janus kinase 3 (JAK3) inhibitors. Cetkovic-Cvrlje M; Tibbles HE Curr Pharm Des; 2004; 10(15):1767-84. PubMed ID: 15180539 [TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinases. Thompson AM; Fry DW; Kraker AJ; Denny WA J Med Chem; 1994 Mar; 37(5):598-609. PubMed ID: 7510340 [TBL] [Abstract][Full Text] [Related]
12. Characterization of an aromatic trifluoromethyl ketone as a new warhead for covalently reversible kinase inhibitor design. Zhang Z; Wang Y; Chen X; Song X; Tu Z; Chen Y; Zhang Z; Ding K Bioorg Med Chem; 2021 Nov; 50():116457. PubMed ID: 34670167 [TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. Rewcastle GW; Palmer BD; Bridges AJ; Showalter HD; Sun L; Nelson J; McMichael A; Kraker AJ; Fry DW; Denny WA J Med Chem; 1996 Feb; 39(4):918-28. PubMed ID: 8632415 [TBL] [Abstract][Full Text] [Related]
20. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts. Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]